Page 319 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P1154 PRE-TREATMENT SERUM VITAMIN D STATUS IS ePOSTERS
P1155 ASSOCIATED WITH SUBSEQUENT RESPONSE TO UDCA IN
PBC
P1156 Xinmin Zhou*, Guanya Guo,Ying Han,Yongquan Shi, China
P1158
P1159 FXR AGONISM WITH OBETICHOLIC ACID MAY ATTENUATE
P1160 BONE MINERAL DENSITY DECREASE IN SUBJECTS WITH
PRIMARY BILIARY CIRRHOSIS
P1161 Albert Pares*, Rich Pencek,Yvette Peters, Tonya Marmon,
P1162 Leigh MacConell, Luciano Adorini, David Shapiro, Michael Trauner,
David Jones, Spain

PROGNOSTIC VALUE OF LIVER HISTOLOGY IN
AUTOIMMUNE HEPATITIS
Lauri Puustinen*, Harri Mustonen, Perttu Arkkila, Sonja Boyd,
Johanna Arola, Martti Färkkilä, Finland

DOES A NORMAL IGG INDICATE HISTOLOGICAL
REMISSION IN AUTOIMMUNE HEPATITIS (AIH)?
Victoria M. Gordon*, Asha K. Dube, Elaine Mcfarlane,
Mohammed A. Karajeh, Dermot C. Gleeson, The United Kingdom

IDENTIFICATION OF SERUM METABOLITES ASSOCIATED
WITH CHOLESTATIC PRURITUS
Albert Pares*, David Balgoma, Anna Reig, Ibon Martinez-Arranz,
Azucena Castro, Antoni Mas, Spain

ANTI-GP210 ANTIBODY IS A SEROLOGICAL MARKER FOR
THE PROGRESSION TO END-STAGE ENLARGED LIVER
WITH MICRONODULAR CIRRHOSIS IN PRIMARY BILIARY
CIRRHOSIS
Minoru Nakamura*, Akira Mori, Tomohiro Tanaka, Noriyo Yamashiki,
Ken Shirabe,Yoshihiko Maehara, Norihiro Kokudo, Shinji Uemoto,
Shinichi Aishima, Japan

ROLE OF PNPLA3 FOR CHOLESTATIC LIVER AND BILE
DUCT INJURY IN MICE
Robert Mc Mahon*, Thierry Claudel, Claudia Fuchs, Erin E. Kershaw,
Michael Trauner, Austria

MULTI-CENTRE AUDIT OF MANAGEMENT AND OUTCOME
IN AUTOIMMUNE HEPATITIS (AIH) – PRELIMINARY
RESULTS
Victoria M. Gordon*, The United Kingdom

Vienna, Austria • April 22–26, 2015 319